Regenerative Biologics, Inc. – FDA Inspection, Dec 6, 2017

Record Details

This FDA Inspection record concerns Regenerative Biologics, Inc., with an inspection on December 6, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Regenerative Biologics, Inc.
Inspection Date: December 6, 2017
Product Type: Biologics
Office: Center for Biologics Evaluation and Research
Person: Karen J. Bak (FDA Associated Person)

View Company Profile

ID · bfd5f227-6894-4e0e-af21-21ba0755b8a4

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number: 1037078
FDA center: Biologics
Project area: Blood and Blood Products

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Regenerative Biologics, Inc.

FDA Inspection

Regenerative Biologics, Inc.December 6, 2017